BridgeBio Neutral Stance From Citi Shakes ATTR-CM Outlook
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Points can sometimes offer greater rewards than cash back. Learn when to choose points to maximize your financial advantages.
27,793 articlesCiti initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Rising financial stress and record home equity are pushing Americans to rethink estate planning. A new review from Tr...
As AI-driven spend accelerates, Fidelity’s MSCI Industrials ETF has posted solid gains, but a cautious investor may f...
A big strategic shift from Lilly could redefine how investors view weight-loss drugs. This article breaks down what h...
Bank of America reinstates Ford with a Buy rating and a $17 target, while Rivian is downgraded to Underperform with a...
Gap reported a Q4 beat on earnings but a sharp post-earnings slide as margins face tariff pressure. The company raise...
Ford reveals a heavy Q4 loss tied to Model e impairments, renewing Reddit-driven skepticism about its EV turnaround a...
With volatility cooling, investors are turning to dividend-focused names. Three no-brainer high-yielding stocks with ...
Oil markets face renewed Hormuz-related risk as traders debate a potential NACHO scenario. Could trump nacho trade re...
Walmart is steering toward higher-margin online services and automation as it grows. The big question for investors i...
A 54-year-old engineer designs a $1.6 million income plan to yield about $9,500 per month by age 67, blending REITs, ...
U.S. stocks and futures react to a fresh batch of analyst calls on Dynatrace, Emerson Electric, Exxon Mobil and more....